AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Semperit AG Holding

Quarterly Report May 10, 2023

760_rns_2023-05-10_387ce12f-955b-4781-a793-d9486b2c3e89.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

Key performance figures

in EUR million 1-3 2023 Change 1-3 2022 2022
Revenue 185.2 2.0% 181.5 779.8
EBITDA 20.8 2.7% 20.3 100.5
EBITDA margin 11.2% +0.1 PP 11.2% 12.9%
EBIT 13.2 4.2% 12.7 62.1
EBIT margin 7.1% +0.1 PP 7.0% 8.0%
Earnings after taxes 8.3 13.2% 7.3 38.4
Earnings per share (EPS)1
, in EUR
0.02 –96.7% 0.75 11.99
Gross cash flow 10.1 –65.8% 29.6 38.4
Return on equity2 0.4% –10.7 PP 11.1% 45.7%

Balance sheet key figures

in EUR million 31.03.2023 Change 31.3.2022 31.12.2022
Total assets 847.6 –15.0% 996.7 842.9
Equity 518.0 –7.6% 560.4 518.2
Equity ratio 61.1% +4.9 PP 56.2% 61.5%
Additions to intangible assets and property,
plant and equipment
5.4 –46.3% 10.0 50.1
Employees (at reporting date) 6,510 –7.1% 7,007 6,528

Sector and segment key figures

in EUR million 1-3 2023 Change 1-3 2022 2022
Industrial Sector = Semperflex + Semperseal + Sempertrans + Semperform
Revenue 176.4 3.2% 171.0 734.0
EBITDA 30.6 15.7% 26.4 125.2
EBIT 23.7 20.6% 19.6 95.9
Semperflex
Revenue 72.6 –9.0% 79.8 328.8
EBITDA 16.7 –14.6% 19.6 82.2
EBIT 13.6 –18.1% 16.6 70.2
Semperseal
Revenue 32.0 –12.7% 36.6 142.1
EBITDA 1.6 –33.1% 2.4 8.3
EBIT 0.0 –98.9% 0.5 –0.6
Sempertrans
Revenue 43.0 52.0% 28.3 151.9
EBITDA 7.3 >100% 1.3 19.7
EBIT 6.2 >100% 0.3 15.5
Semperform
Revenue 28.8 9.8% 26.2 111.1
EBITDA 5.0 54.3% 3.2 15.1
EBIT 3.9 79.7% 2.1 10.8
Medical Sector = Sempermed
Revenue 39.6 –62.7% 106.1 324.2
EBITDA –11.6 n/a 13.3 –15.4
EBIT –13.5 n/a 7.6 –49.5

Note: Rounding differences in the totalling of rounded amounts and percentages may arise from the use of automatic data processing. 1 Earnings per share are only attributable to the core shareholders of Semperit AG Holding (excl. remuneration from hybrid capital). 2 Based on a full-year projection.

Group Management Report

In the first quarter of 2023, the Semperit Group recorded an improvement in its continued operations despite the onset of an economic slowdown. The result of the discontinued operations declined significantly in line with expectations.

Development in the raw material markets

During the first three months, prices for natural rubber (important especially for Sempertrans) and natural latex (important for Sempermed) were significantly lower than in the comparable period of last year (natural rubber –24% and natural latex –18%) on the relevant Asian commodity exchanges.

The average prices for the essential basic raw material butadiene, which is relevant for all segments, were slightly higher in Asia (+2%) and lower in Europe (–9%) in the first quarter of 2023 compared to the same period of the previous year. However, the prices of butadiene derivatives such as butadiene rubber, styrene butadiene rubber and nitrile butadiene rubber did not decrease accordingly due to the energy surcharges still included.

In the first quarter of 2023, prices for nitrile latex, the most important raw material for Sempermed, were significantly below the comparable level of last year due to a continued decline in market demand and despite slightly higher Asian butadiene prices.

Generally, the price trend of heavy fuel oil (HFO), which strongly correlates with the general crude oil price development, is a relevant indicator for the filler carbon black, which is used in the entire Industrial Sector. However, other factors (energy and CO2 surcharges and above all the war in Ukraine) have had a significant impact on carbon black prices in the last 12 months. While in the first quarter of 2023, the average HFO price was 24% lower than in the first quarter of 2022, carbon black prices were very significantly higher than in the same period of the previous year. The increase was caused by the energy and CO2 surcharges on the one hand and, on the other hand especially by the significant drop in carbon black imports into the EU from Russia (–50%) and the discontinuation of imports from Ukraine as well as due to the announced EU sanctions for 2024.

Prices for wire rod – a raw material relevant for the Semperflex, Sempertrans and Semperform segments – decreased by up to 30% after the record levels in the second quarter of 2022 but are still above the five-year average. This development was, on the one hand due to energy prices and, on the other hand, to the current global cooling of the economy and low demand, which led to high inventories of finished and semi-finished materials.

The price of iron ore, the raw material for wire rod, reflects the low demand – especially from China – and declined by 25% year-on-year.

Revenue and earnings performance

Key figures Semperit Group

in EUR million 1-3 2023 Change 1-3 2022
Revenue 185.2 +2.0% 181.5
EBITDA 20.8 +2.7% 20.3
EBITDA margin 11.2% +0.1 PP 11.2%
EBIT 13.2 +4.2% 12.7
EBIT margin 7.1% +0.1 PP 7.0%
Earnings after tax from continued operations 8.3 +13.2% 7.3
Earnings after tax from discontinued operations –7.9 n/a 8.2
Earnings after taxes 0.4 –97.4% 15.5
Additions to intangible assets and property, plant and
equipment 5.4 –46.3% 10.0
Employees (at reporting date) 6,510 –7.1% 7,007

In the first quarter of 2023, the continued operations of the Semperit Group recorded an increase in revenue of +2.0% to EUR 185.2 million compared to the previous year. Revenue in the Industrial Sector increased by +3.2% to EUR 176.4 million, whereas revenue from continued operations in the Medical Sector (in Wimpassing and Sopron) decreased by –16.9% to EUR 8.8 million. The increase in revenue compared to Q1 2022 was mainly driven by the increase in average selling prices in the course of 2022 resulting in average price effect on revenues at 19% in the Industrial Sector – the price effect being in a range between 15% and 29% for the individual segments – thus input factor price increases could be passed on. The volume increase at Sempertrans (+23.0%) is largely attributable to a positive market environment in the mining industry and higher demand. Sales volumes in the other segments fell significantly; at Semperflex, this decline was mainly due to full inventories held by most customers, while in the Semperform segment it was mainly the Engineered Solutions business unit (driven by reduced market activity in the railroad superstructure sector), which fell short of the previous year's figures. Semperseal recorded a significant decline in sales volumes resulting from the weak development of the construction sector.

Inventories of own products of continued operations increased by EUR 7.1 million during the first threee months of the year (1-3 2022: increase of EUR 11.7 million).

Cost of materials (including energy and purchased services) in continued operations decreased by EUR 5.9 million or –5.8% to EUR 96.2 million in the first quarter of 2023. The change was largely due to low production volumes in the Semperflex, Semperseal and Semperform segments, which was offset by the increased production volumes at Sempertrans. Increases in raw material and energy prices also had a counteracting effect, although these were more than offset by lower volumes.

Personnel expenses rose to EUR 52.7 million (+5.7%) in the first quarter of 2023, driven mainly by wage and salary increases that became effective in 2022.

At EUR 24.4 million, other operating expenses were up by +9.5% compared to the same period of the previous year (1-3 2022: EUR 22.3 million). The increase is mainly attributable to expenses from strategic corporate development projects – in particular in connection with the signing of the purchase and assignment agreement for the acquisition of the RICO Group. In addition higher maintenance costs and increased travel costs as business travel picked up again after the corona pandemic were recorded.

At EUR 20.8 million, EBITDA in continued operations largely remained unchanged. The EBITDA margin in continued operations was 11.2% (1-3 2022: 11.2%).

In the first quarter of the year depreciation and amortisation in continued operations remained unchanged at EUR 7.6 million (1-3 2022: EUR 7.6 million). At EUR 13.2 million, EBIT of continued operations also remained on the level of the same period of the previous year.

The financial result of continued operations amounted to EUR –1.9 million (1-3 2022: EUR –2.0 million).

Tax expense in continued operations amounted to EUR 2.9 million (1-3 2022: EUR 3.3 million). In the first quarter of 2023, the effective tax rate of continued operations was 24.1% compared to 27.5% in the same period of the previous year. Here, the effective tax rate refers to income taxes in relation to earnings before tax less profit or loss attributable to redeemable non-controlling interests.

Earnings after tax from continued operations were EUR 8.3 million (1-3 2022: EUR 7.3 million). Earnings after tax from discontinued operations amounted to EUR –7.9 million (1-3 2022: EUR 8.2 million). Further details on discontinued operations will follow in the next chapter.

Earnings after tax (continued and discontinued operations together) amounted to EUR 0.4 million (previous year: EUR 15.5 million). Earnings per share attributable to the shareholders of Semperit AG Holding for the first quarter of 2023 were therefore EUR 0.02 (1-3 2022: EUR 0.75).

Discontinued operations

Revenue from discontinued operations decreased to EUR 39.6 million during the first three months of 2023 (1-3 2022: EUR 106.1 million), particularly due to the end of the corona-related special cycle. Nearly 75% of the decline in sales is attributable to lower average selling prices (ASPs) for gloves.

In discontinued operations, the cost of materials was EUR 36.0 million and thus 42% lower than in the previous year (1-3 2022: EUR 62.2 million) due to lower production volumes and low raw material prices. As pre-packaged surgical gloves are currently, and will continue to be, sold by Semperit Technische Produkte GmbH to Semperit Investments Asia Pte Ltd (currently still part of the Group), which then sells the products of the Sempermed segment to internal and external customers, the cost of materials (of the discontinued operations) amounting to EUR 8.8 million from this supply relationship as a result of the contract manufacturing agreement is included in the cost of materials of the discontinued operations. Personnel expenses decreased by EUR 1.7 million, or 18%, to EUR 7.4 million as a result of the reduction in temporary workers and the reduction in vacation accruals. The 52% decline in other operating expenses to EUR 5.2 million was attributable to the significant drop in freight costs.

As expected, EBITDA in the discontinued operations of the Medical Sector thus decreased significantly from EUR 16.3 million to EUR –9.0 million.

Due to the signing of the SPA with HARPS GLOBAL PTE. LTD., it was possible to determine a fair value for the segment assets of Sempermed as of March 31, 2023 based on the selling price (cash and debt free) and taking into account the price adjustment mechanism provided for in the SPA. Directly attributable disposal costs still expected to be incurred were to be deducted from this. The resulting reversal of impairment losses on the assets of the discontinued operation totaled EUR 1.1 million as of March 31, 2023.

EBIT in the discontinued operations of the Medical Sector fell significantly from EUR 11.0 million to EUR –8.0 million.

Semperit Group "as-if", no separation from the discontinued operation

The following table shows the results based on segment reporting. The segmentation by business areas is based on internal management and reporting and also includes the Sempermed segment as a whole.

This "as-if" presentation shows the figures as if the separation into continued and discontinued operations had not taken place. The earnings figures take into account the continued and discontinued operations as well as all consolidation entries necessary at Group level.

Key figures "as-if" of the Semperit Group, no separation of the discontinued operations

in EUR million 1-3 2023 Change 1-3 2022
Revenue 216.0 –22.0% 277.0
EBITDA 11.7 –68.0% 36.5
EBITDA margin 5.4% –7.8 PP 13.2%
EBIT 2.5 –89.6% 23.7
EBIT margin 1.1% –7.5 PP 8.6%

Dividend

At the 134th Annual General Meeting of Semperit AG Holding (the "Company") held on 25 April 2023, the distribution of a basic dividend of EUR 1.50 per share plus a conditional additional dividend of EUR 3.00 per share was resolved for the 2022 financial year in accordance with the proposal of the Executive Board and the Supervisory Board of the Company under the following conditions: The entitlement to the additional dividend as well as the payment are subject to the conditions precedent that the conditions precedent for the sale of the medical business (Sempermed; initially production of examination gloves including sales organisation) are fulfilled by 16 September 2023, that the medical business has been transferred to the buyer by 31 October 2023, and that Semperit AG Holding has received the full purchase price payable on the day of this closing. Within 7 calendar days after the fulfilment of the above conditions, the Company will obtain a confirmation regarding the fulfilment of the conditions and, immediately after receipt of the confirmation, will announce in a supplementary dividend announcement whether the above conditions have been met. The supplementary dividend announcement will also contain the technical modalities of the supplementary dividend payment, whereby the supplementary dividend is to be paid within 21 calendar days after the fulfilment of the above conditions precedent if the conditions precedent are met. If the conditions precedent do not come into effect, the Company will announce this.

Assets and financial position

Balance sheet

The development of the balance sheet structure as of 31 March 2023 can be summarised as follows:

in EUR million 31.03.2023 Share 31.12.2022 Share Change
Non-current assets 320.9 38% 316.6 38% +1.4%
Current assets 353.2 42% 338.4 40% +4.4%
Assets held for sale 173.4 20% 187.9 22% –7.7%
ASSETS 847.6 100% 842.9 100% +0.6%
Equity1 518.8 61% 519.1 62% –0.1%
Non-current provisions and
liabilities
116.7 14% 115.9 14% +0.7%
Current provisions and liabilities 166.5 20% 161.0 19% +3.4%
Provisions and liabilities held for
sale
45.6 5% 46.9 6% –2.9%
EQUITY AND LIABILITIES 847.6 100% 842.9 100% +0.6%

1 including non-controlling interests

Non-current assets recorded only a slight change. Additions to non-current assets of EUR 6.3 million and a positive FX effect of EUR 2.4 million were mainly offset by write-downs of EUR 7.6 million.

Current assets have increased since 31 December 2022, due to a EUR 12.4 million rise in cash and cash equivalents and a EUR 7.0 million increase in trade receivables.

The increase in current liabilities and provisions resulted primarily from the increase in other provisions by EUR 4.1 million and in other financial liabilities by EUR 3.2 million.

As of 31 March 2023, the Semperit Group exhibited a net cash surplus of EUR 66.1 million, as cash and cash equivalents exceeded financial liabilities (31 December 2022: EUR 54.2 million). The calculated ratio between the net cash surplus (i.e., theoretical negative net indebtedness) and EBITDA as of 31 March 2023 was thus –0.8x (31 December 2022: –0.5x).

With effect from March 31, 2023, new bank financing agreements with a financing volume of up to EUR 360 million were concluded. A financing agreement totaling EUR 250 million consisting of a loan of up to EUR 150 million and a credit facility line of EUR 100 million. In this financing agreement, Semperit AG Holding has committed to compliance with three ESG KPIs, which are also part of the sustainability strategy "30 by 2030". This financing is provided by a group of six Austrian and international banks and replaces the former credit facility line in the amount of EUR 75 million. The second financing agreement in the amount of EUR 110 million was concluded in particular to finance the expansion investment in Odry.

Cash flow

The cash flow statement is prepared jointly for the continued and discontinued operations; no distinction is made between the cash flows of the individual business units. The cash flows from operating, investing and financing activities of the discontinued operation are disclosed in the notes.

The development of the liquidity situation in the first three months of 2023 can be summarised as follows:

in EUR million 1-3 2023 Change 1-3 2022
Cash flows from operating activities 21.1 +20.0% 17.5
Cash flows from investing activities –13.9 –21.2% –17.7
Free cash flow 7.1 n/a –0.1
Cash flows from financing activities –1.2 –81.2% –6.2
Net increase / decrease in cash and cash equivalents 5.0 n/a –4.4
Cash and cash equivalents at the end of the period 162.9 –29.5% 231.1

In the first quarter of 2023, cash flow from operating activities was higher than in the previous year despite the lower result, mainly thanks to the development of the balance from changes in inventories, trade receivables and trade payables, which was positive during the first three months 2023 and amounted to EUR 5.3 million (1-3 2022: funds tied up at EUR 27.3 million).

At EUR 14.5 million, cash expenditures in intangible assets and property, plant and equipment in in the first quarter of 2023 were below the prior-year level (1-3 2022: EUR 17.2 million). The largest investments were made in the Czech Republic with EUR 6.3 million (1-3 2022: EUR 1.5 million), Austria with EUR 3.3 million (1-3 2022: EUR 5.4 million), Germany with EUR 1.4 million (1-3 2022: EUR 0.8 million) and Poland with EUR 1.4 million (1-3 2022: EUR 1.2 million).

Free cash flow (the balance of cash flow from operating activities and cash flow from investing activities) was EUR 7.1; in the first quarter of 2022 it was EUR –0.1 million.

Cash flow from financing activities in the first quarter of 2023 included in particular the repayment of lease liabilities (EUR 1.0 million). In the comparative period, this item included the repayment of a current financial liability in Malaysia amounting to EUR 4.8 million.

Performance of sectors and segments

Industrial Sector

Key figures Industrial Sector

in EUR million 1-3 2023 Change 1-3 2022
Revenue 176.4 +3.2% 171.0
EBITDA 30.6 +15.7% 26.4
EBITDA margin 17.3% +1.9 PP 15.5%
EBIT 23.7 +20.6% 19.6
EBIT margin 13.4% +1.9 PP 11.5%
Additions to intangible assets and property, plant and
equipment
5.0 +16.4% 4.3
Employees (at reporting date) 3,756 –3.2% 3,881
  • Continuing low demand, especially at Semperflex, Semperform and Semperseal, due to partly high customer inventories and continuous destocking, resulted in a lower order intake overall in the first quarter of 2023. In aggregate, the order book of the industrial segments was around 46% below the above-average level of Q1 2022.
  • Revenue increase in total above that of the first quarter of 2022 as lower sales volumes were contrasted by average price levels above last year (following gradual price increases in the course of the 2022 financial year).
  • The cost level in the first quarter 2023 was only slightly below the comparative figure of the previous year – following the sharp increase, particularly in the second and third quarter of 2022, and the incipient recovery since the fourth quarter last year. The slight easing of material costs was offset by a higher level of personnel and other expenses, latter mainly driven by expenses from strategic corporate development projects, in particular in connection with the signing of the purchase and assignment agreement for the acquisition of the RICO Group.

Semperflex segment

Key figures Semperflex

in EUR million 1-3 2023 Change 1-3 2022
Revenue 72.6 –9.0% 79.8
EBITDA 16.7 –14.6% 19.6
EBITDA margin 23.0% –1.5 PP 24.5%
EBIT 13.6 –18.1% 16.6
EBIT margin 18.8% –2.1 PP 20.8%
Additions to intangible assets and property, plant and
equipment
1.6 +54.6% 1.1
Employees (at reporting date) 1,710 –6.7% 1,834

• Continued low demand due to high inventories and destocking by customers.

  • Order intake (especially for hydraulic hoses) significantly below prior year level; consequently order backlog further reduced.
  • Revenue in in the first quarter of 2023 was yoy lower due to volume factors despite higher price levels
  • Slight easing of the cost level, which rose continuously over the 2022 financial year, e.g. due to lower sea freight costs and targeted cost-cutting measures such as staff reductions and various energy-saving measures.

Semperseal segment

Key figures Semperseal

in EUR million 1-3 2023 Change 1-3 2022
Revenue 32.0 –12.7% 36.6
EBITDA 1.6 –33.1% 2.4
EBITDA margin 5.0% –1.5 PP 6.5%
EBIT 0.0 –98.9% 0.5
EBIT margin 0.0% –1.4 PP 1.4%
Additions to intangible assets and property, plant and
equipment
1.9 +2.9% 1.8
Employees (at reporting date) 564 –0.5% 567
  • Weak construction sector continues to impact order intake and is reflected accordingly in comparatively low order backlog.
  • Sales volumes were down from the comparative period in 2022 due to weak demand; as a result, revenue in the first quarter of 2023 was also significantly impacted despite the higher price level.
  • The price level, which increased in the course of the 2022 financial year, only partly offset the cost increases. EBITDA and EBIT therefore declined disproportionately, as did the corresponding margins.

Sempertrans segment

Key figures Sempertrans

in EUR million 1-3 2023 Change 1-3 2022
Revenue 43.0 +52.0% 28.3
EBITDA 7.3 >100% 1.3
EBITDA margin 17.0% +12.5 PP 4.5%
EBIT 6.2 >100% 0.3
EBIT margin 14.4% +13.2 PP 1.2%
Additions to intangible assets and property, plant and
equipment
0.4 +26.7% 0.3
Employees (at reporting date) 888 +1.6% 874
  • Demand in the late-cycle business of Sempertrans during the first three months of 2023 continued to be determined by the positive effects from the favourable price development for mining products and the resulting high demand for conveyor and transportation belts.
  • Order intake was slightly below the comparatively high level of the first quarter of 2022; the order backlog showed a slight decline compared to the record level of recent quarters after orders had been processed.
  • A generally good demand situation resulted in a revenue increase, driven by both volume and price.
  • The cost level in the first quarter of 2023 increased at a lower rate than sales, operational leverage resulted in higher margins..

Semperform segment

Key figures Semperform

in EUR million 1-3 2023 Change 1-3 2022
Revenue 28.8 +9.8% 26.2
EBITDA 5.0 +54.3% 3.2
EBITDA margin 17.2% +5.0 PP 12.2%
EBIT 3.9 +79.7% 2.1
EBIT margin 13.4% +5.2 PP 8.2%
Additions to intangible assets and property, plant and
equipment
1.1 –1.2% 1.1
Employees (at reporting date) 594 –1.9% 605
  • Overall demand in the segment showed a mixed picture; order intake was slightly higher than in the previous year and order volumes were on the same level as in previous year.
  • Overall sales volumes in the first quarter of 2023 were only slightly lower than in the previous year; sales volumes in the Engineered Solutions business unit were lower than in the previous year driven by reduced market activity in the railroad superstructure business.
  • Despite lower volumes, revenue was higher than in the comparative period due to the gradual price increases implemented in 2022.
  • The higher prices also more than compensated for the significant increase in costs since the first quarter of 2022 – though costs declined slightly in the first quarter 2023. This positive effect is also reflected in EBITDA, EBIT and the corresponding margins.

Medical Sector: Sempermed segment

Key figures Sempermed

in EUR million 1-3 2023 Change 1-3 2022
Revenue 39.6 –62.7% 106.1
EBITDA –11.6 n/a 13.3
EBITDA margin –29.3% –41.9 PP 12.6%
EBIT –13.5 n/a 7.6
EBIT margin –34.2% –41.4 PP 7.2%
Additions to intangible assets and property, plant and
equipment
0.7 –84.1% 4.5
Employees (at reporting date) 2,681 –12.2% 3,052

The Medical segment is considered as a whole, without division into discontinued operations and continued operations. The following presentation therefore refers to the entire segment in total.

  • Demand in the first quarter of 2023 was still clearly characterised by customers' destocking and overcapacities regarding production.
  • Sales volumes of surgical gloves were lower than in the comparable period, while the volumes for examination gloves were significantly below the comparable value of 2022.
  • EBITDA was also impacted by higher cost levels in addition to the negative revenue development. The reversal of provisions for gas supply contracts as a result of waivers by suppliers for payments for volumes not taken in 2022 had a positive effect

The headcount as of 31 March 2023 for continued and discontinued operations totalled 6,510 employees (FTE, full-time equivalent), which is –7.1% below the level of 31 March 2022 (7,007). In the Industrial Sector, the number of employees declined compared to 31 March 2022: the Semperflex, Semperform and Semperseal segments saw a decrease in employees of –6.7%, –1.9% and –0.5%, respectively. Meanwhile, the number of employees in the Sempertrans segment increased by 1.6%. The Medical Sector recorded a decrease of –12.2% compared to the previous year.

Executive and Supervisory Board matters

At the 134th Annual General Meeting on 25 April 2023, Thomas Cord Prinzhorn and Marion Weissenberger-Eibl were elected as new members of the Supervisory Board until the end of the Annual General Meeting which resolves on the ratification of actions for the 2025 financial year.

Claus Möhlenkamp and Klaus Erkes were re-elected as Supervisory Board members until the end of the Annual General Meeting which will decide on the discharge for the 2026 financial year.

At the constituent meeting of the Supervisory Board held after the Annual General Meeting, Thomas Cord Prinzhorn was elected Chairman of the Supervisory Board. He takes over from Stefan Fida, who has chaired the supervisory body on an interim basis since December 2022. Stefan Fida was elected Deputy Chairman of the Supervisory Board.

Outlook

For the 2023 financial year, the management of the Semperit Group expects a decline in earnings from continued operations compared to the previous year. This is based on the following assumptions:

The overall economic slowdown is expected to have a noticeable impact on the Industrial Sector, especially in the second and third quarter of 2023. Inventory optimisation programmes on the part of customers already lead to restrained ordering behaviour of customers, as expected. The option to pass on potential further cost increases to customers will depend on the price sensitivity of the respective customers and the dynamics in the segment-specific product markets. As a result, lower sales volumes and increased pressure on margins are to be expected.

In addition, the earnings position of the Semperit Group may of course continue to be significantly influenced by developments such as the Russia-Ukraine conflict: The Executive Board continues to expect a high degree of volatility with regard to the price development and availability of energy in Europe but also of necessary raw materials and supplies.

Further developments in geopolitical trouble spots are still unclear and therefore uncertain. Potential negative effects of inflation and foreign currencies require a high level of attention from the Executive Board.

Against this backdrop, the Executive Board confirms the outlook for the 2023 financial year with EBITDA from continuing operations of between EUR 70 and 90 million, but from today's perspective expects the result to be at the lower end of the range.

With regard to the sale of the medical business, a first closing is expected in mid-2023 or in the following months, depending on the regulatory approval procedures currently underway.

The Medical Sector is still expected to have a negative impact on earnings after taxes. Until the closing, the negative earnings development from the medical business will affect the Semperit Group.

The management is consistently pursuing the implementation of the strategy and is focusing on organic and inorganic growth projects. In this context, the next successful step was taken: on 17 April the Semperit Group announced that it would acquire 100% of the Austrian Rico Group GmbH, a leading global supplier of silicone injection moulding tools and producer of liquid silicone components. Closing is expected in the third quarter of 2023. The long-term potential of the transaction for the Semperit Group lies primarily in high-quality tooling for high-precision and complex solutions and the automation of production steps for the manufacture of large volumes. Furthermore, the acquisition will strengthen market access to North America, where Rico has had its own production facilities for many years.

Note

This outlook is based on the assessments of the Executive Board as of 9 May 2023 and does not take into account the impact of potential acquisitions, divestments, or other unforeseeable structural and economic changes during the remainder of 2023. These assessments are subject to both known and unknown risks and uncertainties, which may result in actual events and outcomes differing from the statements made here.

Consolidated income statement

in EUR thousand Note 1-3 2023 1-3 20221
Revenue 2.2 185,197 181,512
Changes in inventories 7,076 11,661
Own work capitalised 562 581
Operating revenue 192,834 193,753
Other operating income 1,260 764
Cost of material and purchased services 2.3 –96,179 –102,122
Personnel expenses 2.4 –52,719 –49,870
Other operating expenses 2.5 –24,383 –22,260
Earnings before interest, tax, depreciation and amortisation (EBITDA) 2.1 20,814 20,265
Depreciation and amortisation of intangible assets and property, plant and equipment –7,631 –7,612
Earnings before interest and tax (EBIT) 2.1 13,183 12,653
Finance income 286 53
Finance expenses –584 –731
Profit / loss attributable to redeemable non-controlling interests –963 –1,333
Other financial result –687 –29
Financial result –1,948 –2,041
Earnings before taxes 11,235 10,612
Income taxes –2,941 –3,282
Earnings after tax from continued operations 8,294 7,330
Earnings after tax from discontinued operations 2.6 –7,885 8,208
Earnings after taxes 409 15,538
thereof attributable to the shareholders of Semperit AG Holding – from ordinary shares 510 15,494
thereof attributable to non-controlling interests –101 45
Earnings per share in EUR (basic and diluted)2 0.02 0.75
of which earnings per share in EUR from continued operations
(basic and diluted)
0.40 0.36
of which earnings per share in EUR from discontinued operations
(basic and diluted)
–0.38 0.40

1The comparative figures were adjusted (see chapter 2.6).

2 Earnings per share only concern the ordinary shareholders of Semperit AG Holding.

Consolidated statement of comprehensive income

in EUR thousand Note 1-3 2023 1-3 2022
Earnings after taxes 409 15,538
Other comprehensive income that will not be recognised through profit and loss in future
periods 0 –286
Remeasurements of defined benefit plans 0 0
Income tax thereon 0 –286
Other comprehensive income that will be recognised through profit and loss in future
periods –732 5,124
Currency translation differences –732 5,124
Other comprehensive income - total –732 4,838
Comprehensive income –323 20,376
thereof on earnings attributable to the shareholders of Semperit AG Holding – from ordinary
shares –204 20,320
thereof on earnings attributable to non-controlling interests –118 56

Consolidated cash flow statement

in EUR thousand Note 1-3 2023 1-3 20221
Earnings before taxes 11,235 10,612
Earnings before taxes from discontinued operations² –7,794 10,584
Depreciation, amortisation, impairment and reversal of impairment of intangible
assets and property, plant and equipment 6,503 12,829
Gain / loss from disposal of assets (including current and non-current financial
assets) 0 –39
Change in non-current provisions 2,668 467
Profit / loss attributable to redeemable non-controlling interests 963 1,333
Net interest income (including income from securities) 159 666
Income taxes paid –4,025 –11,614
Other non-cash income / expense 420 4,802
Gross cash flow 10,129 29,640
Change in inventories 5,396 –18,732
Change in trade receivables –3,859 –32,660
Change in other receivables and assets 1,028 9,417
Change in trade payables 3,713 24,131
Change in other liabilities and current provisions 4,658 5,752
Cash flows from operating activities 21,065 17,547
Proceeds from sale of property, plant and equipment 36 72
Purchases of intangible assets and property, plant and equipment –14,469 –17,170
Interest received 416 85
Investment grants received 84 37
Acquisition of financial assets 0 –711
Cash flows from investing activities –13,932 –17,687
Cash receipts from current and non-current financial liabilities –3 –4,825
Repayment of lease liabilities –946 –771
Repayment of liabilities from capital repayment to non-controlling interests in
subsidiaries 0 –343
Interest paid –221 –268
Cash flows from financing activities –1,169 –6,206
Currency translation differences –968 1,910
Net change in cash and cash equivalents 4,996 –4,436
Cash and cash equivalents at the beginning of the period related to continued
operations 106,631 109,416
Plus cash and cash equivalents related to discontinued operations 51,274 126,123
Cash and cash equivalents at the beginning of the period (consolidated
balance sheet value) 157,906 235,539
Cash and cash equivalents at the end of the period 162,902 231,103
Less cash and cash equivalents related to discontinued operations 43,856 94,498
Cash and cash equivalents at the end of the period related to continued
operations(consolidated balance sheet value) 119,046 136,605

1The comparative figures were adjusted (see chapter 2.6).

2 Earnings before taxes from discontinued operations comprise earnings before taxes of EUR –7,694 thousand (previous year: EUR 10,584 thousand) and transaction costs of EUR –100 thousand (previous year: EUR 0 thousand), see section 2.6.

Consolidated balance sheet

in EUR thousand Note 31.03.2023 31.12.2022
Intangible assets 5,780 6,283
Property, plant and equipment 295,227 293,531
Other financial assets 5,666 5,628
Other assets 8,477 5,842
Deferred tax assets 5,788 5,344
Non-current assets 320,938 316,628
Inventories 125,213 128,214
Trade receivables 95,855 88,861
Other financial assets 1,806 2,457
Other assets 11,050 11,241
Current tax receivables 239 1,010
Cash and cash equivalents 119,046 106,631
Current assets 353,209 338,414
Assets held for sale 3 173,413 187,875
ASSETS 847,560 842,917
Share capital 21,359 21,359
Capital reserves 21,503 21,503
Retained earnings 482,647 482,136
Currency translation reserve –7,540 –6,825
Equity attributable to the shareholders of Semperit AG Holding 517,970 518,174
Non-controlling interests 852 970
Equity 518,822 519,145
Provisions 32,470 32,134
Liabilities from redeemable non-controlling interests 13,080 12,162
Financial liabilities 37,960 37,956
Trade payables 110 52
Other financial liabilities 19,078 18,925
Other liabilities 2,037 1,995
Deferred tax assets 11,950 12,629
Non-current provisions and liabilities 116,684 115,854
Provisions 27,553 23,442
Liabilities from redeemable non-controlling interests 6,506 6,745
Financial liabilities 15,020 14,503
Trade payables 62,226 63,890
Other financial liabilities 12,769 9,553
Other liabilities 34,774 35,289
Current tax liabilities 7,656 7,586
Current provisions and liabilities 166,503 161,009
Provisions and liabilities held for sale 3 45,550 46,909
EQUITY AND LIABILITIES 847,560 842,917

Consolidated statement of changes in equity

in EUR thousand Note Share
capital
Capital
reserves
Retained
earnings
Currency
translation
reserve
Total Non
control
ling
interests
Total
equity
As at 01.01.2022 21,359 21,503 512,216 –14,956 540,122 1,028 541,151
Earnings after taxes 0 0 15,494 0 15,494 45 15,538
Other comprehensive
income
0 0 –286 5,113 4,827 11 4,838
Comprehensive income 0 0 15,208 5,113 20,320 56 20,376
As at 31.03.2022 21,359 21,503 527,424 –9,844 560,443 1,084 561,527
As at 01.01.2023 21,359 21,503 482,136 –6,824 518,174 970 519,145
Earnings after taxes 0 0 510 0 510 –101 409
Other comprehensive
income
0 0 0 –715 –715 –17 –732
Comprehensive income 0 0 510 –715 –204 –118 –323
As at 31.03.2023 21,359 21,503 482,647 –7,539 517,970 852 518,822

Notes to the interim group financial statements (condensed)

1. General

1.1. Basic preparation principals

The interim group financial report has been prepared in accordance with International Financial Reporting Standards (IFRSs) and is based on the regulations for interim financial statements (IAS 34).

For more information on accounting and valuation methods of the Semperit Group, please see the consolidated financial statements as at 31 December 2022, which in this regard form the basis for this interim group financial report.

The reporting currency is the euro, with figures rounded to the nearest thousand, unless expressly stated otherwise. Rounding differences in the totalling of rounded amounts and percentages may arise from the automatic processing of data.

On 16 December 2022, the management of the Semperit Group reached an agreement with the Southeast Asian glove producer, HARPS GLOBAL PTE. LTD., which is based in Singapore and runs manufacturing operations in Malaysia, on the sale of the Sempermed segment. As far as the production of examination gloves and the associated sales organisation are concerned, the conditions for presentation as discontinued operations were given; for the time being, however, the production of surgical gloves will remain with the Semperit Group and thus will be presented in continued operations.

The interim group financial report of the Semperit Group as at 31 March 2023 have not been fully audited or reviewed by the Group's auditor

1.2. New and amended accounting standards

The following new/revised Standards and Interpretations were applied for the first time in the first quarter of 2023:

Endorsement Mandatory application
for the Semperit
Group
Effects on the
Semperit Group
New standards and interpretations
IFRS 17 Insurance Contracts 19 November 2021 1 January 2023 no
Amended standards
IAS 1 Amendments to the presentation of the financial statement:
disclosure of accounting standards
2 March 2022 1 January 2023 no
IAS 8 Amendments to accounting policies, amendments to
accounting estimates and errors: definition of accounting
estimates
2 March 2022 1 January 2023 no
IAS 12 Amendments to deferred taxes related to assets and liabilities
arising from a single transaction
11 August 2022 1 January 2023 no
Miscellan
eous
Amendments to the initial application of IFRS 17 and IFRS 9 –
comparative information
8 September 2022 1 January 2023 no

2. Performance

2.1. Segment reporting

Neither the presentation nor the measurement requirements pursuant to IFRS 5 applicable to discontinued operations were used in internal segment reporting.

1-3 2023 in EUR thousand Semper
med
Semper
flex
Semper
trans
Semper
seal
Semper
form
Corporate
Center
Group
Elimina
tions
Total
Revenue 39,572 72,649 43,018 31,977 28,793 0 0 216,010
Revenue with other segments 0 91 0 0 42 0 –133 0
EBITDA –11,604 16,734 7,327 1,588 4,954 –7,318 0 11,681
EBIT –13,544 13,624 6,191 6 3,860 –7,675 0 2,462
Depreciation and amortisation of
intangible assets and property,
plant and equipment
–3,068 –3,110 –1,136 –1,582 –1,094 –357 0 –10,347
Reversal of impairment of
intangible assets and property,
plant and equipment
1,128 0 0 0 0 0 0 1,128
Trade working capital 40,026 73,299 34,081 25,351 23,030 –6,482 0 189,306
Additions to intangible assets
and property, plant and
equipment1
714 1,630 436 1,865 1,075 112 0 5,833

1 Excluding right-of-use assets in accordance with IFRS 16

Discontinued +
1-3 2023 in EUR thousand Total Adjustments continued
operation
Discontinued
operation
Continued
operation
Revenue 216,010 8,755 224,764 39,568 185,197
Revenue with other segments 0 0 0 0 0
EBITDA 11,681 100 11,781 –9,034 20,814
EBIT 2,462 2,816 5,277 –7,906 13,183
Depreciation and amortisation of
intangible assets and property,
plant and equipment
–10,347 2,716 –7,631 0 –7,631
Reversal of impairment of
intangible assets and property,
plant and equipment
1,128 0 1,128 1,128 0
Trade working capital 189,306 0 189,306 30,464 158,843
Additions to intangible assets
and property, plant and
equipment1
5,833 0 5,833 467 5,366

1 Excluding right-of-use assets in accordance with IFRS 16

1-3 2022 in EUR thousand Semper
med
Semper
flex
Semper
trans
Semper
seal
Semper
form
Corporate
Center
Group
Elimina
tions
Total
Revenue 106,061 79,814 28,307 36,628 26,226 0 0 277,036
Revenue with other segments 0 52 0 64 28 0 –144 0
EBITDA 13,327 19,589 1,273 2,374 3,210 –3,244 0 36,531
EBIT 7,600 16,635 334 519 2,148 –3,534 0 23,702
Depreciation and amortisation of
intangible assets and property,
plant and equipment
–5,727 –2,954 –939 –1,855 –1,062 –290 0 –12,829
Trade working capital 78,782 75,527 25,098 25,060 22,006 –4,310 0 222,163
Additions to intangible assets
and property, plant and
equipment1
4,492 1,054 344 1,813 1,088 1,206 0 9,997

1 Excluding right-of-use assets in accordance with IFRS 16

Discontinued +
continued
Discontinued Continued
1-3 2022 in EUR thousand Total Adjustments operation operation operation
Revenue 277,036 10,530 287,566 106,054 181,512
Revenue with other segments 0 0 0 0 0
EBITDA 36,531 0 36,531 16,266 20,265
EBIT 23,702 0 23,702 11,050 12,653
Depreciation and amortisation of
intangible assets and property,
plant and equipment –12,829 0 –12,829 –5,216 –7,612
Trade working capital 222,163 0 222,163 74,801 147,362
Additions to intangible assets
and property, plant and
equipment1 9,997 0 9,997 4,146 5,852

1 Excluding right-of-use assets in accordance with IFRS 16

2.2. Revenue

1-3 2023 in EUR thousand Semper
med
Semper
flex
Semper
trans
Semper
seal
Semper
form
Group
Western Europe 5 42,625 18,031 25,506 17,688 103,856
Asia 8,755 5,861 5,677 95 5,229 25,617
North America 0 11,849 7,695 2,937 2,323 24,803
Eastern Europe 0 11,364 2,008 3,439 3,136 19,946
Central and South
America
0 619 4,589 0 285 5,493
Africa 0 204 4,806 0 128 5,138
Australia and
Oceania
0 127 212 0 4 343
Revenue 8,759 72,649 43,018 31,977 28,793 185,197
1-3 2022 in EUR thousand Semper
med
Semper
flex
Semper
trans
Semper
seal
Semper
form
Group
Western Europe 7 47,101 12,841 29,296 16,466 105,711
Asia 10,530 5,781 5,800 145 4,964 27,219
North America 0 9,271 2,382 2,337 1,244 15,234
Eastern Europe 0 15,695 3,390 4,847 3,110 27,042
Central and South
America 0 1,243 582 3 384 2,213
Africa 0 533 1,589 0 45 2,167
Australia and
Oceania 0 190 1,723 0 12 1,926
Revenue 10,537 79,814 28,307 36,628 26,226 181,512

2.3. Cost of materials and purchased services

in EUR thousand 1-3 2023 1-3 2022
Cost of materials 82,183 88,850
Energy expenses 10,382 9,900
Production-related maintenance costs 2,226 1,979
Purchased services 1,389 1,393
Total 96,179 102,122

2.4. Personnel expenses

in EUR thousand 1-3 2023 1-3 2022
Wages 20,170 19,488
Salaries 22,362 20,637
Severance payments 352 301
Retirement benefit expenses 296 199
Statutory social security expenses and other compulsory wage-related payments 8,828 8,544
Other social security expenses 709 701
Total 52,719 49,870

2.5. Other operating expenses

1-3 2023 1-3 2022
6,326 6,894
3,580 2,725
2,968 2,022
1,396 1,206
1,360 1,118
1,220 582
1,173 69
905 549
655 1,274
555 456
499 714
439 513
396 243
252 275
174 162
166 171
65 68
–347 63
2,602 3,157
24,383 22,260

2.6. Earnings after taxes from discontinued operations

The income statement for the discontinued operations is presented below:

in EUR thousand 1-3 2023 1-3 2022
Revenue 39,568 106,054
Changes in inventories –277 –8,347
Own work capitalised 19 410
Operating revenue 39,310 98,117
Other operating income 163 100
Cost of material and purchased services –35,976 –62,165
Personnel expenses –7,379 –9,051
Other operating expenses –5,152 –10,735
Earnings before interest, tax, depreciation and amortisation (EBITDA) –9,034 16,266
Depreciation and amortisation of intangible assets and property, plant and
equipment
0 –5,216
Reversal of impairment of intangible assets and property, plant and equipment 1,128 0
Earnings before interest and tax (EBIT) –7,906 11,050
Finance income 100 38
Finance expenses –13 –28
Other financial result 125 –476
Financial result 212 –466
Earnings before taxes –7,694 10,584
Income taxes –91 –2,375
Earnings after taxes –7,785 8,208
Transaction costs recognized –100 0
Income taxes on transactions costs recognized 0 0
Result from deconsolidation 0 0
Reclassification of other income to profit/loss for the period 0 0
Subtotal –100 0
Result from discontinued operations –7,885 8,208
thereof earnings attributable to the shareholders of Semperit AG –7,784 8,164
thereof attributable to non-controlling interests –101 45

Earnings after taxes arising from the fair-value measurement less costs to sell correspond to the reversal of impairment losses on intangible assets and property, plant and equipment.

The expenses for material and purchased services comprise the following:

in EUR thousand 1-3 2023 1-3 2022
Cost of materials 25,462 49,387
Energy expenses 9,995 11,976
Production-related maintenance costs 456 721
Purchased services 62 81
Total 35,976 62,165

Other operating expenses comprise the following:

in EUR thousand 1-3 2023 1-3 2022
Outgoing freight 2,121 7,869
Miscellaneous 3,031 2,866
Total 5,152 10,735

Cash flows from the operating, investing and financing activities of the discontinued operation:

in EUR thousand 1-3 2023 1-3 2022
Cash flows from operating activities –2,121 24,721
Cash flows from investing activities –712 –6,582
Cash flows from financing activities –146 –5,346

3. Assets held for sale and provisions and liabilities held for sale

in EUR thousand 31.03.2023 31.12.2022
Intangible assets 100 99
Property, plant and equipment 75,422 75,328
Other financial assets 50 81
Other assets 10 24
Non-current assets 75,583 75,532
Inventories 35,141 38,597
Trade receivables 14,443 17,520
Other financial assets 324 454
Other assets 2,256 2,528
Current tax receivables 1,810 1,970
Cash and cash equivalents 43,856 51,274
Current assets 97,830 112,343
Assets held for sale 173,413 187,875
Currency translation differences –19,725 –16,989
Provisions 7,024 4,747
Other financial liabilities 631 734
Other liabilities 327 400
Deferred tax assets 10 7
Non-current provisions and liabilities 7,993 5,887
Provisions 10,516 10,904
Trade payables 19,121 19,792
Other financial liabilities 2,026 2,299
Other liabilities 2,737 3,524
Current tax liabilities 3,157 4,503
Current provisions and liabilities 37,557 41,022
Provisions and liabilities held for sale 45,550 46,909

Contact

Semperit AG Holding

Am Belvedere 10 1100 Vienna, Austria Tel.: +43 1 79 777 0 Fax: +43 1 79 777 600 www.semperitgroup.com/en

Investor Relations

Judit Helenyi Director Investor Relations Tel.: +43 1 79 777 310 www.semperitgroup.com/en/ir

Addresses of the Semperit Group

www.semperitgroup.com/en/contact

Contacts of the Semperit Group

Ownership and publisher: Semperit Aktiengesellschaft Holding, Am Belvedere 10, 1100 Vienna, Austria, Produced in-house with firesys GmbH, www.firesys.de

Disclaimer

The terms "Semperit" or "Semperit Group" in this report refer to the group; "Semperit AG Holding" or "Semperit Aktiengesellschaft Holding" is used to refer to the parent company (individual company).

We have prepared this report and verified the information it contains with the greatest possible care. Nevertheless, rounding, typesetting and printing errors cannot be ruled out. Rounding of differences in the summation rounded amounts and percentages may arise from the automatic processing of data.

The forecasts, plans and forward-looking statements contained in this report are based on the knowledge and information available and the assessments made at the time that this report was prepared (editorial deadline: 09 May 2023). As is true of all forward-looking statements, these statements are subject to risk and uncertainties. As a result, actual events may deviate significantly from these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of planned targets or for any other forward-looking statements. Words such as "expect," "want", "believe," "anticipate," "includes," "plan," "assumes," "estimate," "projects," "intends," "should," "will," "shall," or variations of such words are generally part of forward-looking statements.

Furthermore, there is no guarantee that the contents are complete.

Statements referring to people are valid for both men and women.

This report has been written in German and English. In case of doubt, the German version shall take precedence.

Financial Calendar 2023 10.05.2023 Report on Q1 2023

10.08.2023 Half-year financial report 2023
08.11.2023 Report on Q1-3 2023

Talk to a Data Expert

Have a question? We'll get back to you promptly.